Applicable under specific humanitarian or medical aid programs with prior approval from the Sudanese Ministry of Health.
Additional Information
No additional information available.
Last updated: 1 year ago
News and Updates
Recent News
US Imposes New Tariffs on Somatotropin Imports from Sudan
The United States has introduced a 15% tariff on somatotropin and its derivatives (HS Code: 2937.11) imported from Sudan, citing unfair trade practices and the need to protect domestic producers.
2023-10-15
Impact: This tariff is likely to reduce the volume of somatotropin imports from Sudan to the US, increasing costs for US buyers and potentially shifting demand to other global suppliers.
Sudan Seeks WTO Mediation Over US Trade Restrictions on Somatotropin
Sudan has approached the World Trade Organization (WTO) to challenge US restrictions on somatotropin trade, arguing that the measures violate international trade agreements.
2023-09-20
Impact: Pending WTO mediation could either escalate trade tensions or lead to a resolution, affecting the flow of somatotropin and its analogues between the two countries.
Recent bilateral talks between the US and Sudan focused on reducing export barriers for somatotropin and structural analogues, with Sudan pushing for eased sanctions.
2023-08-05
Impact: Successful negotiations could increase Sudan's export capacity to the US, potentially lowering prices for US consumers of these products.
Policy Updates
US Updates Import Regulations for Somatotropin from Sudan
The US Department of Commerce has updated import regulations, requiring additional certification for somatotropin (HS Code: 2937.11) and its derivatives from Sudan to ensure compliance with safety and trade standards.
Date: 2023-10-01
Sudan Revises Export Policy for Somatotropin Products
Sudan has introduced new export licensing requirements for somatotropin and related products to monitor and control the outflow of these goods, aiming to align with international trade norms.
